1. Sampling, extrapolation to prove FCA liability approved by district court
The U.S. District Court for the Eastern District of Tennessee ruled it is permissible for the government to extrapolate from a random sample to establish the elements of False Claims Act liability.
2. SCOTUS blocks parts of Texas abortion law
The U.S. Supreme Court stopped Texas from putting certain abortion-clinic restrictions into place that would have significantly reduced the number of clinics operating in the state.
3. CareMed Pharmaceutical Services settles False Claims Act case for $10M
Lake Success, N.Y.-based CareMed Pharmaceutical Services agreed to pay $10 million to resolve allegations it submitted false claims for automatic refills of drugs that were not actually received by patients and their physicians.
4. Alere data breach class suit dismissed
A federal judge in California dismissed a class-action lawsuit brought against Alere Home Monitoring following a data breach.
5. PhRMA challenges 340B drug discounts again
The Pharmaceutical Research and Manufacturers of America filed a second lawsuit challenging HHS’ implementation of the 340B drug discount program.
6. Clinical Lab Partners settles False Claims Act case
Newington, Conn.-based Clinical Lab Partners agreed to pay $145,789.34 to settle allegations the company submitted false claims to Medicare.
7. Pennsylvania threatens to sue Highmark over Medicare Advantage plan
The Pennsylvania Insurance Department, Attorney General and Department of Health sent a letter to Highmark pledging to take legal action against the health insurer over its new zero premium Medicare Advantage plan.
More articles on health law:
Malpractice reform doesn’t stop physicians from practicing defensive medicine
65 False Claims Act cases unsealed since June: 5 things to know
10 latest healthcare industry lawsuits, settlements